CN104119475B - A kind of surface-functionalized micro-nano polymer gel particle and preparation method thereof - Google Patents
A kind of surface-functionalized micro-nano polymer gel particle and preparation method thereof Download PDFInfo
- Publication number
- CN104119475B CN104119475B CN201410290931.XA CN201410290931A CN104119475B CN 104119475 B CN104119475 B CN 104119475B CN 201410290931 A CN201410290931 A CN 201410290931A CN 104119475 B CN104119475 B CN 104119475B
- Authority
- CN
- China
- Prior art keywords
- polymer gel
- reaction
- micro
- gel particle
- solvent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 229920000642 polymer Polymers 0.000 title claims abstract description 95
- 239000007863 gel particle Substances 0.000 title claims abstract description 80
- 238000002360 preparation method Methods 0.000 title claims abstract description 22
- 238000006243 chemical reaction Methods 0.000 claims abstract description 26
- 239000003431 cross linking reagent Substances 0.000 claims abstract description 26
- OFNISBHGPNMTMS-UHFFFAOYSA-N 3-methylideneoxolane-2,5-dione Chemical compound C=C1CC(=O)OC1=O OFNISBHGPNMTMS-UHFFFAOYSA-N 0.000 claims abstract description 24
- 239000000126 substance Substances 0.000 claims abstract description 21
- HNJBEVLQSNELDL-UHFFFAOYSA-N pyrrolidin-2-one Chemical group O=C1CCCN1 HNJBEVLQSNELDL-UHFFFAOYSA-N 0.000 claims abstract description 12
- 239000002245 particle Substances 0.000 claims description 60
- 239000000178 monomer Substances 0.000 claims description 35
- 239000002904 solvent Substances 0.000 claims description 32
- 239000003814 drug Substances 0.000 claims description 15
- MYRTYDVEIRVNKP-UHFFFAOYSA-N 1,2-Divinylbenzene Chemical compound C=CC1=CC=CC=C1C=C MYRTYDVEIRVNKP-UHFFFAOYSA-N 0.000 claims description 14
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 14
- 229940079593 drug Drugs 0.000 claims description 14
- 150000001335 aliphatic alkanes Chemical class 0.000 claims description 13
- 150000002576 ketones Chemical class 0.000 claims description 13
- 238000000034 method Methods 0.000 claims description 11
- 239000003505 polymerization initiator Substances 0.000 claims description 11
- 238000003756 stirring Methods 0.000 claims description 11
- 229910052757 nitrogen Inorganic materials 0.000 claims description 9
- 239000000203 mixture Substances 0.000 claims description 8
- 239000003999 initiator Substances 0.000 claims description 7
- 230000000694 effects Effects 0.000 claims description 6
- 238000005406 washing Methods 0.000 claims description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 6
- 239000002202 Polyethylene glycol Substances 0.000 claims description 4
- 150000008064 anhydrides Chemical group 0.000 claims description 4
- 238000001246 colloidal dispersion Methods 0.000 claims description 4
- 125000004386 diacrylate group Chemical group 0.000 claims description 4
- 229920001223 polyethylene glycol Polymers 0.000 claims description 4
- DBCAQXHNJOFNGC-UHFFFAOYSA-N 4-bromo-1,1,1-trifluorobutane Chemical compound FC(F)(F)CCCBr DBCAQXHNJOFNGC-UHFFFAOYSA-N 0.000 claims description 3
- STVZJERGLQHEKB-UHFFFAOYSA-N ethylene glycol dimethacrylate Substances CC(=C)C(=O)OCCOC(=O)C(C)=C STVZJERGLQHEKB-UHFFFAOYSA-N 0.000 claims description 3
- 230000032050 esterification Effects 0.000 claims description 2
- 238000005886 esterification reaction Methods 0.000 claims description 2
- 229910052736 halogen Inorganic materials 0.000 claims description 2
- 150000002367 halogens Chemical class 0.000 claims description 2
- 238000007127 saponification reaction Methods 0.000 claims description 2
- 229910052723 transition metal Inorganic materials 0.000 claims description 2
- 150000003624 transition metals Chemical class 0.000 claims description 2
- 239000004971 Cross linker Substances 0.000 claims 6
- 238000006392 deoxygenation reaction Methods 0.000 claims 2
- -1 fully dissolve Substances 0.000 claims 2
- 238000001291 vacuum drying Methods 0.000 claims 2
- 238000011938 amidation process Methods 0.000 claims 1
- 238000010276 construction Methods 0.000 claims 1
- 230000005611 electricity Effects 0.000 claims 1
- 239000003446 ligand Substances 0.000 claims 1
- ZIUHHBKFKCYYJD-UHFFFAOYSA-N n,n'-methylenebisacrylamide Chemical compound C=CC(=O)NCNC(=O)C=C ZIUHHBKFKCYYJD-UHFFFAOYSA-N 0.000 claims 1
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 abstract description 19
- 125000004018 acid anhydride group Chemical group 0.000 abstract description 8
- 238000010521 absorption reaction Methods 0.000 abstract description 6
- 206010028980 Neoplasm Diseases 0.000 abstract description 4
- 238000000926 separation method Methods 0.000 abstract description 4
- 201000011510 cancer Diseases 0.000 abstract description 3
- 238000003745 diagnosis Methods 0.000 abstract description 3
- 208000006454 hepatitis Diseases 0.000 abstract description 3
- 231100000283 hepatitis Toxicity 0.000 abstract description 3
- 238000001514 detection method Methods 0.000 abstract description 2
- 239000003937 drug carrier Substances 0.000 abstract description 2
- 102000004169 proteins and genes Human genes 0.000 abstract description 2
- 108090000623 proteins and genes Proteins 0.000 abstract description 2
- JHIVVAPYMSGYDF-UHFFFAOYSA-N cyclohexanone Chemical compound O=C1CCCCC1 JHIVVAPYMSGYDF-UHFFFAOYSA-N 0.000 description 22
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 18
- 239000000047 product Substances 0.000 description 13
- 239000000243 solution Substances 0.000 description 13
- DKPFZGUDAPQIHT-UHFFFAOYSA-N Butyl acetate Natural products CCCCOC(C)=O DKPFZGUDAPQIHT-UHFFFAOYSA-N 0.000 description 12
- 238000003917 TEM image Methods 0.000 description 12
- FUZZWVXGSFPDMH-UHFFFAOYSA-N hexanoic acid Chemical compound CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 description 12
- 238000009826 distribution Methods 0.000 description 10
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 6
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 6
- IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 description 6
- 239000012046 mixed solvent Substances 0.000 description 6
- 238000006116 polymerization reaction Methods 0.000 description 6
- 230000015572 biosynthetic process Effects 0.000 description 5
- 239000007795 chemical reaction product Substances 0.000 description 5
- 230000000052 comparative effect Effects 0.000 description 5
- 239000000463 material Substances 0.000 description 5
- OZAIFHULBGXAKX-UHFFFAOYSA-N 2-(2-cyanopropan-2-yldiazenyl)-2-methylpropanenitrile Chemical compound N#CC(C)(C)N=NC(C)(C)C#N OZAIFHULBGXAKX-UHFFFAOYSA-N 0.000 description 4
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 4
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 4
- CRZQGDNQQAALAY-UHFFFAOYSA-N Methyl benzeneacetate Chemical compound COC(=O)CC1=CC=CC=C1 CRZQGDNQQAALAY-UHFFFAOYSA-N 0.000 description 4
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 4
- XSIFPSYPOVKYCO-UHFFFAOYSA-N butyl benzoate Chemical compound CCCCOC(=O)C1=CC=CC=C1 XSIFPSYPOVKYCO-UHFFFAOYSA-N 0.000 description 4
- XUPYJHCZDLZNFP-UHFFFAOYSA-N butyl butanoate Chemical compound CCCCOC(=O)CCC XUPYJHCZDLZNFP-UHFFFAOYSA-N 0.000 description 4
- 238000010668 complexation reaction Methods 0.000 description 4
- MTZQAGJQAFMTAQ-UHFFFAOYSA-N ethyl benzoate Chemical compound CCOC(=O)C1=CC=CC=C1 MTZQAGJQAFMTAQ-UHFFFAOYSA-N 0.000 description 4
- FKRCODPIKNYEAC-UHFFFAOYSA-N ethyl propionate Chemical compound CCOC(=O)CC FKRCODPIKNYEAC-UHFFFAOYSA-N 0.000 description 4
- 125000000524 functional group Chemical group 0.000 description 4
- MLFHJEHSLIIPHL-UHFFFAOYSA-N isoamyl acetate Chemical compound CC(C)CCOC(C)=O MLFHJEHSLIIPHL-UHFFFAOYSA-N 0.000 description 4
- PQLMXFQTAMDXIZ-UHFFFAOYSA-N isoamyl butyrate Chemical compound CCCC(=O)OCCC(C)C PQLMXFQTAMDXIZ-UHFFFAOYSA-N 0.000 description 4
- 239000004816 latex Substances 0.000 description 4
- 229920000126 latex Polymers 0.000 description 4
- QPJVMBTYPHYUOC-UHFFFAOYSA-N methyl benzoate Chemical compound COC(=O)C1=CC=CC=C1 QPJVMBTYPHYUOC-UHFFFAOYSA-N 0.000 description 4
- 239000002105 nanoparticle Substances 0.000 description 4
- 229910052760 oxygen Inorganic materials 0.000 description 4
- 239000001301 oxygen Substances 0.000 description 4
- PGMYKACGEOXYJE-UHFFFAOYSA-N pentyl acetate Chemical compound CCCCCOC(C)=O PGMYKACGEOXYJE-UHFFFAOYSA-N 0.000 description 4
- 230000008569 process Effects 0.000 description 4
- CIHOLLKRGTVIJN-UHFFFAOYSA-N tert‐butyl hydroperoxide Chemical compound CC(C)(C)OO CIHOLLKRGTVIJN-UHFFFAOYSA-N 0.000 description 4
- OMPJBNCRMGITSC-UHFFFAOYSA-N Benzoylperoxide Chemical compound C=1C=CC=CC=1C(=O)OOC(=O)C1=CC=CC=C1 OMPJBNCRMGITSC-UHFFFAOYSA-N 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 235000019400 benzoyl peroxide Nutrition 0.000 description 3
- 230000005540 biological transmission Effects 0.000 description 3
- 239000012876 carrier material Substances 0.000 description 3
- 238000005119 centrifugation Methods 0.000 description 3
- 239000007810 chemical reaction solvent Substances 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 229920001577 copolymer Polymers 0.000 description 3
- 239000002270 dispersing agent Substances 0.000 description 3
- 239000004005 microsphere Substances 0.000 description 3
- 230000035484 reaction time Effects 0.000 description 3
- 230000009257 reactivity Effects 0.000 description 3
- JLIDRDJNLAWIKT-UHFFFAOYSA-N 1,2-dimethyl-3h-benzo[e]indole Chemical compound C1=CC=CC2=C(C(=C(C)N3)C)C3=CC=C21 JLIDRDJNLAWIKT-UHFFFAOYSA-N 0.000 description 2
- HNAGHMKIPMKKBB-UHFFFAOYSA-N 1-benzylpyrrolidine-3-carboxamide Chemical compound C1C(C(=O)N)CCN1CC1=CC=CC=C1 HNAGHMKIPMKKBB-UHFFFAOYSA-N 0.000 description 2
- LGJCFVYMIJLQJO-UHFFFAOYSA-N 1-dodecylperoxydodecane Chemical compound CCCCCCCCCCCCOOCCCCCCCCCCCC LGJCFVYMIJLQJO-UHFFFAOYSA-N 0.000 description 2
- HFZLSTDPRQSZCQ-UHFFFAOYSA-N 1-pyrrolidin-3-ylpyrrolidine Chemical compound C1CCCN1C1CNCC1 HFZLSTDPRQSZCQ-UHFFFAOYSA-N 0.000 description 2
- FRIBMENBGGCKPD-UHFFFAOYSA-N 3-(2,3-dimethoxyphenyl)prop-2-enal Chemical compound COC1=CC=CC(C=CC=O)=C1OC FRIBMENBGGCKPD-UHFFFAOYSA-N 0.000 description 2
- MLLAPOCBLWUFAP-UHFFFAOYSA-N 3-Methylbutyl benzoate Chemical compound CC(C)CCOC(=O)C1=CC=CC=C1 MLLAPOCBLWUFAP-UHFFFAOYSA-N 0.000 description 2
- XMVSKCALPYUKIX-UHFFFAOYSA-N C(CC)OC=O.C1=CC=CC=C1 Chemical compound C(CC)OC=O.C1=CC=CC=C1 XMVSKCALPYUKIX-UHFFFAOYSA-N 0.000 description 2
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 2
- BDAGIHXWWSANSR-UHFFFAOYSA-M Formate Chemical compound [O-]C=O BDAGIHXWWSANSR-UHFFFAOYSA-M 0.000 description 2
- JGFBQFKZKSSODQ-UHFFFAOYSA-N Isothiocyanatocyclopropane Chemical compound S=C=NC1CC1 JGFBQFKZKSSODQ-UHFFFAOYSA-N 0.000 description 2
- RJUFJBKOKNCXHH-UHFFFAOYSA-N Methyl propionate Chemical compound CCC(=O)OC RJUFJBKOKNCXHH-UHFFFAOYSA-N 0.000 description 2
- 150000001408 amides Chemical class 0.000 description 2
- WYUHQMAEVAHKNJ-UHFFFAOYSA-N benzene;2-propan-2-ylperoxypropane Chemical compound C1=CC=CC=C1.CC(C)OOC(C)C WYUHQMAEVAHKNJ-UHFFFAOYSA-N 0.000 description 2
- DULCUDSUACXJJC-UHFFFAOYSA-N benzeneacetic acid ethyl ester Natural products CCOC(=O)CC1=CC=CC=C1 DULCUDSUACXJJC-UHFFFAOYSA-N 0.000 description 2
- QUKGYYKBILRGFE-UHFFFAOYSA-N benzyl acetate Chemical compound CC(=O)OCC1=CC=CC=C1 QUKGYYKBILRGFE-UHFFFAOYSA-N 0.000 description 2
- OBNCKNCVKJNDBV-UHFFFAOYSA-N butanoic acid ethyl ester Natural products CCCC(=O)OCC OBNCKNCVKJNDBV-UHFFFAOYSA-N 0.000 description 2
- PWLNAUNEAKQYLH-UHFFFAOYSA-N butyric acid octyl ester Natural products CCCCCCCCOC(=O)CCC PWLNAUNEAKQYLH-UHFFFAOYSA-N 0.000 description 2
- 238000007385 chemical modification Methods 0.000 description 2
- 229910052802 copper Inorganic materials 0.000 description 2
- 239000010949 copper Substances 0.000 description 2
- BLCKNMAZFRMCJJ-UHFFFAOYSA-N cyclohexyl cyclohexyloxycarbonyloxy carbonate Chemical compound C1CCCCC1OC(=O)OOC(=O)OC1CCCCC1 BLCKNMAZFRMCJJ-UHFFFAOYSA-N 0.000 description 2
- LSXWFXONGKSEMY-UHFFFAOYSA-N di-tert-butyl peroxide Chemical compound CC(C)(C)OOC(C)(C)C LSXWFXONGKSEMY-UHFFFAOYSA-N 0.000 description 2
- 238000012377 drug delivery Methods 0.000 description 2
- 238000007306 functionalization reaction Methods 0.000 description 2
- 238000002329 infrared spectrum Methods 0.000 description 2
- 229910010272 inorganic material Inorganic materials 0.000 description 2
- 239000011147 inorganic material Substances 0.000 description 2
- GJRQTCIYDGXPES-UHFFFAOYSA-N iso-butyl acetate Natural products CC(C)COC(C)=O GJRQTCIYDGXPES-UHFFFAOYSA-N 0.000 description 2
- 229940094941 isoamyl butyrate Drugs 0.000 description 2
- FGKJLKRYENPLQH-UHFFFAOYSA-M isocaproate Chemical compound CC(C)CCC([O-])=O FGKJLKRYENPLQH-UHFFFAOYSA-M 0.000 description 2
- OQAGVSWESNCJJT-UHFFFAOYSA-N isovaleric acid methyl ester Natural products COC(=O)CC(C)C OQAGVSWESNCJJT-UHFFFAOYSA-N 0.000 description 2
- 239000002502 liposome Substances 0.000 description 2
- 229920002521 macromolecule Polymers 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 229940095102 methyl benzoate Drugs 0.000 description 2
- 229940017219 methyl propionate Drugs 0.000 description 2
- UUIQMZJEGPQKFD-UHFFFAOYSA-N n-butyric acid methyl ester Natural products CCCC(=O)OC UUIQMZJEGPQKFD-UHFFFAOYSA-N 0.000 description 2
- XNLICIUVMPYHGG-UHFFFAOYSA-N pentan-2-one Chemical compound CCCC(C)=O XNLICIUVMPYHGG-UHFFFAOYSA-N 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- BWJUFXUULUEGMA-UHFFFAOYSA-N propan-2-yl propan-2-yloxycarbonyloxy carbonate Chemical compound CC(C)OC(=O)OOC(=O)OC(C)C BWJUFXUULUEGMA-UHFFFAOYSA-N 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- DCKVNWZUADLDEH-UHFFFAOYSA-N sec-butyl acetate Chemical compound CCC(C)OC(C)=O DCKVNWZUADLDEH-UHFFFAOYSA-N 0.000 description 2
- 238000001179 sorption measurement Methods 0.000 description 2
- 238000007619 statistical method Methods 0.000 description 2
- 229920001059 synthetic polymer Polymers 0.000 description 2
- 230000008685 targeting Effects 0.000 description 2
- GJBRNHKUVLOCEB-UHFFFAOYSA-N tert-butyl benzenecarboperoxoate Chemical compound CC(C)(C)OOC(=O)C1=CC=CC=C1 GJBRNHKUVLOCEB-UHFFFAOYSA-N 0.000 description 2
- 238000012719 thermal polymerization Methods 0.000 description 2
- 102000009027 Albumins Human genes 0.000 description 1
- 108010088751 Albumins Proteins 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 229920001661 Chitosan Polymers 0.000 description 1
- 238000005033 Fourier transform infrared spectroscopy Methods 0.000 description 1
- 238000001157 Fourier transform infrared spectrum Methods 0.000 description 1
- 229920002732 Polyanhydride Polymers 0.000 description 1
- 229920000954 Polyglycolide Polymers 0.000 description 1
- 229920001710 Polyorthoester Polymers 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 230000010933 acylation Effects 0.000 description 1
- 238000005917 acylation reaction Methods 0.000 description 1
- 230000004520 agglutination Effects 0.000 description 1
- 230000009435 amidation Effects 0.000 description 1
- 238000007112 amidation reaction Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 1
- 125000003636 chemical group Chemical group 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 230000000536 complexating effect Effects 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 238000005538 encapsulation Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 239000006249 magnetic particle Substances 0.000 description 1
- 230000007721 medicinal effect Effects 0.000 description 1
- 239000000693 micelle Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 229920000771 poly (alkylcyanoacrylate) Polymers 0.000 description 1
- 229920001308 poly(aminoacid) Polymers 0.000 description 1
- 229920000747 poly(lactic acid) Polymers 0.000 description 1
- 229920002037 poly(vinyl butyral) polymer Polymers 0.000 description 1
- 229920001610 polycaprolactone Polymers 0.000 description 1
- 239000004632 polycaprolactone Substances 0.000 description 1
- 239000004633 polyglycolic acid Substances 0.000 description 1
- 239000004626 polylactic acid Substances 0.000 description 1
- 239000012429 reaction media Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000012798 spherical particle Substances 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 238000006557 surface reaction Methods 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 229910000859 α-Fe Inorganic materials 0.000 description 1
Landscapes
- Medicinal Preparation (AREA)
- Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
Abstract
本发明公开一种聚合物凝胶粒子,特别是一种表面功能化的微纳米聚合物凝胶粒子及其制备方法。所述聚合物凝胶粒子的化学结构中同时含有酸酐基团和吡咯烷酮基团,而且通过交联剂连接为交联结构。所述聚合物凝胶粒子由亚甲基丁二酸酐、N-乙烯基吡咯烷酮、交联剂反应形成,亚甲基丁二酸酐、N-乙烯基吡咯烷酮、交联剂三者之间的用量比范围为:(2~4)∶(1~2)∶(1~2);优选地,亚甲基丁二酸酐、N-乙烯基吡咯烷酮、交联剂三者之间的用量比范围为:(2~3)∶(1~1.5)∶(1~1.5)。所述一种表面功能化的微纳米聚合物凝胶粒子,可用于药物载体、靶向制剂、癌症诊断、肝炎检测、蛋白分离、细胞分离、免疫吸收等生物医药领域。
The invention discloses a polymer gel particle, in particular a surface-functionalized micro-nano polymer gel particle and a preparation method thereof. The chemical structure of the polymer gel particles contains acid anhydride groups and pyrrolidone groups at the same time, and is connected to form a cross-linked structure through a cross-linking agent. The polymer gel particles are formed by the reaction of methylene succinic anhydride, N-vinylpyrrolidone, and a crosslinking agent, and the amount ratio between methylenesuccinic anhydride, N-vinylpyrrolidone, and the crosslinking agent is The range is: (2 ~ 4): (1 ~ 2): (1 ~ 2); preferably, the range of the amount ratio between methylene succinic anhydride, N-vinylpyrrolidone and crosslinking agent is: (2~3):(1~1.5):(1~1.5). The surface-functionalized micro-nano polymer gel particles can be used in biomedical fields such as drug carriers, targeted preparations, cancer diagnosis, hepatitis detection, protein separation, cell separation, and immune absorption.
Description
技术领域technical field
本发明属于新材料领域,涉及一种聚合物凝胶粒子,特别是一种表面功能化的微纳米聚合物凝胶粒子及其制备方法。The invention belongs to the field of new materials, and relates to a polymer gel particle, in particular to a surface-functionalized micro-nano polymer gel particle and a preparation method thereof.
背景技术Background technique
聚合物微纳米粒具有比表面积大、吸附性强、凝集作用大及表面反应能力强等特性,在医学和生物化学领域的应用日益广泛,它可用于临床检验、药物输送、癌症和肝炎的诊断、细胞的标记、识别、分离和培养、放射免疫固相载体及免疫吸收等方面。Polymer micro-nanoparticles have the characteristics of large specific surface area, strong adsorption, strong agglutination, and strong surface reaction ability. They are widely used in the fields of medicine and biochemistry. They can be used in clinical testing, drug delivery, and diagnosis of cancer and hepatitis. , cell labeling, identification, isolation and culture, radioimmunosolid phase carrier and immune absorption, etc.
靶向药物能够选择性地到达人体特定病变组织,并缓慢释放出有效成分,以期最大限度地增强药物的疗效,同时降低药物系统的毒副作用,减少给药次数,因此靶向给药制剂已成为现代药剂学的重要内容。为了使药物能选择性地到达靶组织发挥药效,就需要将药物以化学键结合或采用物理吸附、包裹等方式附载在具有导向性作用的载体上,制成一种“导弹式”药物制剂。靶向药物技术的关键在于载体材料的选择。Targeted drugs can selectively reach specific diseased tissues of the human body and slowly release active ingredients in order to maximize the efficacy of the drug, while reducing the side effects of the drug system and reducing the number of administrations. Therefore, targeted drug delivery preparations have become Important content of modern pharmacy. In order for the drug to selectively reach the target tissue to exert its medicinal effect, it is necessary to attach the drug to a carrier with guiding effect through chemical bonding or physical adsorption, encapsulation, etc., to make a "missile" drug preparation. The key to targeted drug technology lies in the selection of carrier materials.
目前已经开发的载体材料包括无机材料、生物大分子、合成高分子等材料。无机材料主要是铁氧体磁性粒子、二氧化硅粒子等材料,其制备工艺比较成熟,主要问题是表面没有有机官能团,难以吸附或键合药物或其他生物分子,实际应用时需要对其表面进行复杂的化学修饰,工艺繁琐。天然的生物大分子有壳聚糖及其衍生物、聚氨基酸、白蛋白、脂质体等,这些材料的生物相容性和降解性好,但主要是溶解或分散于水中,以松散的大分子线团或胶束状态存在,不能形成实体的球形粒子,所以对药物的包覆率低,转运效率低,而且也存在表面难以修饰的问题,导致脂质体等纳米粒子对组织细胞的特异识别性较低,靶向性不强。合成高分子载体材料包括聚酐、聚原酸酯、聚氰基丙烯酸烷基酯、聚己内酯、聚乳酸、聚乙醇酸及其共聚物等。这类材料成分上各具特点,具有一定的可修饰性,但功能基团的反应性不强,而且功能基团比较单一,需要通过特定的后续反应以达到实际应用需求,另外以这类材料为成分的微纳米粒制备工艺比较复杂。The carrier materials that have been developed so far include inorganic materials, biological macromolecules, synthetic polymers and other materials. Inorganic materials are mainly ferrite magnetic particles, silica particles and other materials. The preparation process is relatively mature. The main problem is that there are no organic functional groups on the surface, which makes it difficult to adsorb or bond drugs or other biomolecules. Complex chemical modification, cumbersome process. Natural biomacromolecules include chitosan and its derivatives, polyamino acids, albumin, liposomes, etc. These materials have good biocompatibility and degradability, but they are mainly dissolved or dispersed in water, with loose macromolecules Molecular coils or micelles exist and cannot form solid spherical particles, so the coating rate of drugs is low, the transport efficiency is low, and there is also the problem that the surface is difficult to modify, resulting in the specificity of liposomes and other nanoparticles to tissue cells. The identification is low and the targeting is not strong. Synthetic polymer carrier materials include polyanhydrides, polyorthoesters, polyalkylcyanoacrylates, polycaprolactone, polylactic acid, polyglycolic acid and their copolymers, etc. These materials have their own characteristics and can be modified to a certain extent, but the reactivity of the functional groups is not strong, and the functional groups are relatively single, and specific follow-up reactions are required to meet the actual application requirements. The preparation process of micro-nanoparticles as ingredients is relatively complicated.
本发明旨在提出一种同时具备高反应性酸酐基团和高络合性吡咯烷酮基团的微纳米聚合物凝胶粒子及其制备方法。The present invention aims to propose a micro-nano polymer gel particle having both highly reactive acid anhydride groups and highly complexing pyrrolidone groups and a preparation method thereof.
发明内容Contents of the invention
本发明的目的是克服现有微纳米聚合物粒子的不足,提供一种表面功能化的微纳米聚合物凝胶粒子及其制备方法。The purpose of the present invention is to overcome the shortcomings of the existing micro-nano polymer particles, and provide a surface-functionalized micro-nano polymer gel particle and a preparation method thereof.
所述聚合物凝胶粒子表面含有反应性功能基团,有利于通过化学键合方式附载特定的活性物质、药物、生物分子、肿瘤靶向剂、抗体等等,从而实现微纳米聚合物凝胶粒子的多功能化。The surface of the polymer gel particles contains reactive functional groups, which are beneficial to attach specific active substances, drugs, biomolecules, tumor targeting agents, antibodies, etc. through chemical bonding, thereby realizing micro-nano polymer gel particles multifunctional.
本发明提供如下技术方案:The present invention provides following technical scheme:
一种表面功能化的微纳米聚合物凝胶粒子,所述聚合物凝胶粒子,所述聚合物包含如下结构单元:A surface-functionalized micro-nano polymer gel particle, the polymer gel particle, the polymer comprising the following structural units:
其中n为10-10000,优选100-1000。Where n is 10-10000, preferably 100-1000.
优选地,上述结构单元通过交联剂连接为交联结构。Preferably, the above-mentioned structural units are connected into a cross-linked structure through a cross-linking agent.
所述聚合物凝胶粒子的化学结构中同时含有酸酐基团和吡咯烷酮基团。The chemical structure of the polymer gel particles contains both acid anhydride groups and pyrrolidone groups.
所述酸酐基团具有高反应活性,可以发生水解、皂化、酯化、酰化、酰胺化等反应。The acid anhydride group has high reactivity and can undergo reactions such as hydrolysis, saponification, esterification, acylation, and amidation.
所述吡咯烷酮基团具有络合反应活性,可以与含有空轨道的过渡金属、吸电的卤素、药物分子等进行配位络合。The pyrrolidone group has complexation reactivity, and can carry out coordination complexation with transition metals containing empty orbitals, charge-absorbing halogens, drug molecules, and the like.
所述同时含有酸酐基团和吡咯烷酮基团的共聚高分子微纳米粒是一种新型化学组成的凝胶粒子,其粒子表面及凝胶网络内部含有高反应活性的酸酐基团和吡咯烷酮基团,这些功能性化学基团可以发生一系列化学、生物化学的后续反应,从而为聚合物凝胶粒子的化学修饰、生物修饰、药物络合等后功能化提供了极大的方便,因而在生物医药领域具有广阔的应用价值。The copolymerized polymer micro-nanoparticles containing acid anhydride groups and pyrrolidone groups at the same time are gel particles with a new chemical composition, and the surface of the particles and the interior of the gel network contain highly reactive acid anhydride groups and pyrrolidone groups. These functional chemical groups can undergo a series of chemical and biochemical follow-up reactions, which provide great convenience for the post-functionalization of polymer gel particles such as chemical modification, biological modification, and drug complexation. The field has broad application value.
本发明同时公开一种表面功能化的微纳米聚合物凝胶粒子的制备方法,所述制备方法包含以下步骤:The present invention also discloses a preparation method of surface-functionalized micro-nano polymer gel particles. The preparation method comprises the following steps:
(一)将反应性单体、聚合引发剂和溶剂混合,形成混合反应液;(1) mixing reactive monomers, polymerization initiators and solvents to form a mixed reaction solution;
(二)将上述混合反应液进行通氮排氧,然后加热,反应形成灰蓝至乳白色胶体分散体系;(2) Nitrogen and oxygen discharge are carried out to the above-mentioned mixed reaction solution, and then heated to react to form a grayish blue to milky white colloidal dispersion system;
(三)分离步骤(二)所得产物,并将分离出的产物进行烘干。(3) separating the product obtained in step (2), and drying the separated product.
优选地,所述方法包含以下步骤:Preferably, the method comprises the steps of:
(1)按设定比例一次性投料反应性单体、聚合引发剂和溶剂,充分溶解,混合均匀;(1) Feed reactive monomer, polymerization initiator and solvent at one time according to the set ratio, fully dissolve and mix evenly;
(2)将步骤(1)所配溶液进行通氮排氧,时间15-30min;(2) Nitrogen and oxygen are passed through the solution prepared in step (1) for 15-30 minutes;
(3)将步骤(2)的溶液体系置于恒温水浴中加热,反应温度45-120℃,反应时间5-600min,搅拌速率0-450rpm;(3) Heat the solution system in step (2) in a constant temperature water bath, the reaction temperature is 45-120°C, the reaction time is 5-600min, and the stirring rate is 0-450rpm;
(4)反应完毕后,形成灰蓝至乳白色胶体分散体系,将得到的产物用高速离心机分离,转速5000-12000rpm;(4) After the reaction is completed, a gray-blue to milky-white colloidal dispersion system is formed, and the obtained product is separated with a high-speed centrifuge at a speed of 5000-12000rpm;
(5)用步骤(1)所述溶剂对离心产物进行洗涤,再次离心分离、洗涤,重复3-5次,以洗尽残余单体和引发剂;(5) washing the centrifuged product with the solvent described in step (1), centrifuging and washing again, repeating 3-5 times, to wash away the residual monomer and initiator;
(6)将最终的离心产物放入真空烘箱,于50-80℃温度下烘干至恒重,得到微纳米聚合物凝胶粒子。(6) Put the final centrifuged product into a vacuum oven, and dry it at a temperature of 50-80° C. to a constant weight to obtain micro-nano polymer gel particles.
其中,所述反应性单体包含:亚甲基丁二酸酐、N-乙烯基吡咯烷酮、交联剂。优选地,所述反应性单体由亚甲基丁二酸酐、N-乙烯基吡咯烷酮和交联剂组成。Wherein, the reactive monomer includes: methylene succinic anhydride, N-vinylpyrrolidone, and a crosslinking agent. Preferably, the reactive monomer consists of methylene succinic anhydride, N-vinylpyrrolidone and a crosslinking agent.
其中,亚甲基丁二酸酐、N-乙烯基吡咯烷酮、交联剂三者之间的用量比范围为:(2~4)∶(1~2)∶(1~2)。优选地,亚甲基丁二酸酐、N-乙烯基吡咯烷酮、交联剂三者之间的用量比范围为:(2~3)∶(1~1.5)∶(1~1.5)。本申请的发明人预料不到地发现,三者的比例在前述范围内能够得到微纳米聚合物凝胶粒子,且所述粒子的球形性好、粒度均匀。Wherein, the range of the usage ratio among methylene succinic anhydride, N-vinylpyrrolidone and crosslinking agent is: (2-4): (1-2): (1-2). Preferably, the range of the amount ratio among methylene succinic anhydride, N-vinylpyrrolidone and crosslinking agent is: (2-3):(1-1.5):(1-1.5). The inventors of the present application unexpectedly found that micro-nano polymer gel particles can be obtained when the ratio of the three is within the aforementioned range, and the particles have good sphericity and uniform particle size.
其中,所述交联剂为具有两个以上可聚合结构的分子,这类分子包括但不限于:二乙烯基苯、二甲基丙烯酸乙二醇酯、N,N′-亚甲基双丙烯酰胺、聚乙二醇双丙烯酸酯。Wherein, the crosslinking agent is a molecule having more than two polymerizable structures, such molecules include but not limited to: divinylbenzene, ethylene glycol dimethacrylate, N,N'-methylenebispropylene Amide, polyethylene glycol diacrylate.
所述单体含量占溶液总量的1%-50%,优选5%-20%;其中,交联剂含量占其他单体总量的0.1%-15%,优选1%-10%。The content of the monomer accounts for 1%-50% of the total solution, preferably 5%-20%; wherein, the content of the crosslinking agent accounts for 0.1%-15% of the total amount of other monomers, preferably 1%-10%.
其中,所述聚合引发剂选自本领域专业技术人员所公知的热聚合引发剂,这类引发剂包括但不限于:异丙苯过氧化氢、叔丁基过氧化氢、过氧化二异丙苯、过氧化二特丁基、过氧化十二酰、过氧化二苯甲酰、过氧化苯甲酸特丁酯、过氧化二碳酸二异丙基酯、过氧化二碳酸二环己酯、偶氮二异丁腈、偶氮二异庚腈中的至少一种。Wherein, the polymerization initiator is selected from thermal polymerization initiators known to those skilled in the art, such initiators include but not limited to: cumene hydroperoxide, tert-butyl hydroperoxide, diisopropyl peroxide Benzene, di-tert-butyl peroxide, lauryl peroxide, dibenzoyl peroxide, tert-butyl peroxybenzoate, diisopropyl peroxydicarbonate, dicyclohexyl peroxydicarbonate, At least one of azobisisobutyronitrile and azobisisoheptanonitrile.
所述聚合引发剂含量占溶液总量的0.01%-0.5%,优选0.01%-0.1%。The content of the polymerization initiator accounts for 0.01%-0.5% of the total solution, preferably 0.01%-0.1%.
其中,所述溶剂对于实现本发明中的亚甲基丁二酸酐、N-乙烯基吡咯烷酮、交联剂的聚合反应从而得到微纳米聚合物凝胶粒子非常关键。所述溶剂必须对于亚甲基丁二酸酐、N-乙烯基吡咯烷酮、交联剂和引发剂都有良好的溶解作用,以保证反应前为均相体系;而且,所述溶剂必须对于所生成的共聚物大分子链不能溶解,当大分子链达到一定的临界长度后便从介质中沉析出来,形成微纳米聚合物凝胶粒子分散于反应溶剂当中。Wherein, the solvent is very critical for realizing the polymerization reaction of methylene succinic anhydride, N-vinylpyrrolidone and crosslinking agent in the present invention to obtain micronano polymer gel particles. Described solvent must all have good dissolving effect for methylene succinic anhydride, N-vinylpyrrolidone, linking agent and initiator, to guarantee that it is homogeneous system before reaction; And, described solvent must be for generated The macromolecular chain of the copolymer cannot be dissolved, and when the macromolecular chain reaches a certain critical length, it will precipitate out of the medium to form micro-nano polymer gel particles dispersed in the reaction solvent.
所述溶剂选自以下三类:(a)有机酸烷基酯:甲酸酯、乙酸乙酯、乙酸丁酯、乙酸异丁酯、乙酸仲丁酯、乙酸戊酯、乙酸异戊酯、乙酸苄酯、丙酸甲酯、丙酸乙酯、丙酸丁酯、丁酸甲酯、丁酸乙酯、丁酸丁酯、丁酸异戊酯、苯甲酸甲酯、苯甲酸乙酯、苯甲酸丙酯、苯甲酸丁酯、苯甲酸异戊酯、苯乙酸甲酯、苯乙酸乙酯;(b)酮类:丙酮、甲乙酮、戊酮、环己酮;(c)烷烃类:正己烷、环己烷、正庚烷。优选地,所述溶剂由有机酸烷基酯、酮类、烷烃类组合而成。Described solvent is selected from following three classes: (a) organic acid alkyl ester: formate, ethyl acetate, butyl acetate, isobutyl acetate, sec-butyl acetate, pentyl acetate, isopentyl acetate, acetic acid Benzyl ester, Methyl propionate, Ethyl propionate, Butyl propionate, Methyl butyrate, Ethyl butyrate, Butyl butyrate, Isoamyl butyrate, Methyl benzoate, Ethyl benzoate, Benzene Propyl formate, butyl benzoate, isoamyl benzoate, methyl phenylacetate, ethyl phenylacetate; (b) ketones: acetone, methyl ethyl ketone, pentanone, cyclohexanone; (c) alkanes: n-hexane , cyclohexane, n-heptane. Preferably, the solvent is composed of organic acid alkyl esters, ketones, and alkanes.
优选地,有机酸烷基酯、酮类、烷烃类三者之间的用量比范围为:(5~8)∶(1~3)∶(1~2)。优选地,有机酸烷基酯、酮类、烷烃类三者之间的用量比范围为:(6~7)∶(1~2)∶(1~1.5)。更优选地,所述溶剂由乙酸丁酯、环己酮和环己烷组成。Preferably, the range of the usage ratio among organic acid alkyl esters, ketones and alkanes is: (5-8):(1-3):(1-2). Preferably, the range of the usage ratio among organic acid alkyl esters, ketones and alkanes is: (6-7):(1-2):(1-1.5). More preferably, the solvent consists of butyl acetate, cyclohexanone and cyclohexane.
需要特别说明的是,本聚合反应体系在无分散剂添加的情况下亦可正常反应并得到微纳米聚合物凝胶粒子,这是本发明制备方法与一般聚合物凝胶粒子制备方法的不同。It should be noted that this polymerization reaction system can also react normally and obtain micro-nano polymer gel particles without adding a dispersant, which is the difference between the preparation method of the present invention and the general polymer gel particle preparation method.
其中,所述搅拌速率为0-450rpm,即在搅拌速率为0的情况下,亦可正常反应并制备聚合物乳胶粒子,与搅拌条件下的反应相比,粒子的形态和大小会有所不同。这是本发明制备聚合物乳胶粒子工艺方法的又一特色。Wherein, the stirring rate is 0-450rpm, that is, when the stirring rate is 0, the polymer latex particles can also be reacted normally and prepared. Compared with the reaction under stirring conditions, the shape and size of the particles will be different . This is another feature of the process for preparing polymer latex particles of the present invention.
本发明的微纳米聚合物凝胶粒子用透射电子显微镜进行形貌表征,用激光粒度分析仪进行粒径统计分析,用傅里叶红外光谱进行化学结构分析。The micro-nano polymer gel particle of the present invention is characterized by a transmission electron microscope, a particle size statistical analysis by a laser particle size analyzer, and a chemical structure analysis by a Fourier transform infrared spectrum.
本发明所制备的微纳米聚合物凝胶粒子,其粒径可以通过反应时间、单体浓度、交联剂浓度、溶剂组合等工艺参数进行调控,粒径范围在10nm-10μm之间,优选在20nm-5μm之间。The micro-nano polymer gel particles prepared by the present invention can have a particle size that can be regulated by process parameters such as reaction time, monomer concentration, crosslinking agent concentration, solvent combination, etc., and the particle size range is between 10nm-10μm, preferably between Between 20nm-5μm.
本发明所制备的微纳米聚合物凝胶粒子的粒度均匀,其粒径分布指数在1.0-1.3之间,粒径分布比较窄。The prepared micro-nano polymer gel particle has uniform particle size, its particle size distribution index is between 1.0-1.3, and the particle size distribution is relatively narrow.
本发明所制备的微纳米聚合物凝胶粒子粒度均匀,其化学结构分析表明,聚合物分子结构中同时包含酸酐基团和吡咯烷酮基团,是一种新型化学组成的表面功能化的微纳米聚合物凝胶粒子。The particle size of the micro-nano polymer gel prepared by the present invention is uniform, and its chemical structure analysis shows that the molecular structure of the polymer contains acid anhydride groups and pyrrolidone groups at the same time, which is a new chemical composition of surface-functionalized micro-nano polymer gel particles.
上述技术方案所公开的一种表面功能化的微纳米聚合物凝胶粒子及其制备方法,具有以下优点:A surface-functionalized micro-nano polymer gel particle and a preparation method thereof disclosed in the above technical solution have the following advantages:
1)设计合成一种新型化学组成的共聚高分子微纳米凝胶粒子,其粒子表面和凝胶网络内部含有高反应活性的酸酐基团和吡咯烷酮基团,可以方便地进行化学修饰、生物修饰、药物络合等后功能化,在生物医药领域有广阔的应用价值;1) Design and synthesize a new chemical composition of copolymerized polymer micro-nano gel particles, which contain highly reactive anhydride groups and pyrrolidone groups on the surface of the particles and inside the gel network, which can be easily chemically modified, biologically modified, Post-functionalization such as drug complexation has broad application value in the field of biomedicine;
2)粒子制备的聚合工艺简单,反应可以在没有分散剂和没有搅拌的条件下进行,具有自分散、自稳定的特征;2) The polymerization process of particle preparation is simple, and the reaction can be carried out without dispersant and stirring, and has the characteristics of self-dispersion and self-stabilization;
3)微纳米聚合物凝胶粒子的粒径可以通过反应时间、单体浓度、交联剂浓度、溶剂组合等工艺参数进行控制;3) The particle size of micro-nano polymer gel particles can be controlled by process parameters such as reaction time, monomer concentration, cross-linking agent concentration, and solvent combination;
4)产物通过离心容易分离,所用反应介质属低毒化学品,而且可回收利用。4) The product is easily separated by centrifugation, and the reaction medium used is a low-toxic chemical and can be recycled.
本发明提供的一种表面功能化的微纳米聚合物凝胶粒子,可以用于药物载体、靶向制剂、癌症诊断、肝炎检测、蛋白分离、细胞分离、免疫吸收等生物医药领域。The surface-functionalized micro-nano polymer gel particles provided by the invention can be used in biomedical fields such as drug carriers, targeted preparations, cancer diagnosis, hepatitis detection, protein separation, cell separation, and immune absorption.
附图说明Description of drawings
图1为实施例1的微纳米聚合物凝胶粒子的透射电子显微镜照片。FIG. 1 is a transmission electron micrograph of the micro-nano polymer gel particles of Example 1.
图2为实施例2的微纳米聚合物凝胶粒子的透射电子显微镜照片。2 is a transmission electron micrograph of the micro-nano polymer gel particles of Example 2.
图3为实施例3的微纳米聚合物凝胶粒子的透射电子显微镜照片。3 is a transmission electron micrograph of the micro-nano polymer gel particles of Example 3.
图4为实施例4的微纳米聚合物凝胶粒子的透射电子显微镜照片。FIG. 4 is a transmission electron micrograph of the micro-nano polymer gel particles of Example 4. FIG.
图5为实施例5的微纳米聚合物凝胶粒子的透射电子显微镜照片。5 is a transmission electron micrograph of the micro-nano polymer gel particles of Example 5.
图6为实施例6的微纳米聚合物凝胶粒子的透射电子显微镜照片。FIG. 6 is a transmission electron micrograph of the micro-nano polymer gel particles of Example 6. FIG.
图7为本发明微纳米聚合物凝胶粒子的化学结构红外光谱图。Fig. 7 is an infrared spectrogram of the chemical structure of the micro-nano polymer gel particles of the present invention.
具体实施方式detailed description
下面结合附图和实施例,对本发明的技术方案做进一步详细说明,以下实施例用于说明本发明,但不用于限制本发明的范围。The technical solutions of the present invention will be described in further detail below in conjunction with the accompanying drawings and examples. The following examples are used to illustrate the present invention, but are not intended to limit the scope of the present invention.
本发明所公开的一种表面功能化的微纳米聚合物凝胶粒子,其形貌如图1-6透射电子显微镜图片所示。所述聚合物凝胶粒子的粒径可以通过工艺参数调控,而且粒度比较均匀。The appearance of a surface-functionalized micro-nano polymer gel particle disclosed in the present invention is shown in Figures 1-6 of transmission electron microscope pictures. The particle size of the polymer gel particles can be regulated by process parameters, and the particle size is relatively uniform.
本发明所公开的一种表面功能化的微纳米聚合物凝胶粒子,其化学结构如图7红外光谱图所示。1779cm-1和1850cm-1附近是酸酐基团的特征吸收,1666cm-1附近是吡咯烷酮环中羰基(C=O)的振动吸收,该吸收峰由于受到C-N键的共振影响所以很宽,波数跨度在30-35cm-1。红外光谱表明本发明的微纳米聚合物凝胶粒子的分子结构中同时包含酸酐基团和吡咯烷酮基团,是一种新型化学组成的表面功能化的微纳米聚合物凝胶粒子。The chemical structure of a surface-functionalized micro-nano polymer gel particle disclosed in the present invention is shown in the infrared spectrum diagram in FIG. 7 . The vicinity of 1779cm -1 and 1850cm -1 is the characteristic absorption of the anhydride group, and the vicinity of 1666cm -1 is the vibration absorption of the carbonyl (C=O) in the pyrrolidone ring. This absorption peak is very broad due to the resonance of the CN bond, and the wave number span At 30-35cm -1 . Infrared spectrum shows that the molecular structure of the micro-nano polymer gel particle of the present invention contains both acid anhydride groups and pyrrolidone groups, and is a surface-functionalized micro-nano polymer gel particle with a new chemical composition.
微纳米聚合物凝胶粒子的制备方法:将反应单体、聚合引发剂、溶剂按设定比例一次性投料至装有氮气导管、冷凝管、搅拌器及温度计的反应器中,充分溶解混合均匀;通氮排氧15-30min;将溶液体系置于恒温水浴中加热,温度45-120℃,时间5-600min,搅拌速率0-450rpm;反应完毕后,将得到的产物用高速离心机分离,转速5000-12000rpm;用溶剂对离心产物进行洗涤,再次离心分离、洗涤,重复3-5次;将最终的离心产物放入真空烘箱,于60℃温度下烘干至恒重。The preparation method of micro-nano polymer gel particles: Feed the reaction monomer, polymerization initiator, and solvent into the reactor equipped with nitrogen conduit, condenser, stirrer, and thermometer at one time according to the set ratio, fully dissolve and mix evenly ; Nitrogen and oxygen exhaust for 15-30min; heat the solution system in a constant temperature water bath, the temperature is 45-120°C, the time is 5-600min, the stirring rate is 0-450rpm; after the reaction is completed, the obtained product is separated by a high-speed centrifuge, The rotation speed is 5000-12000rpm; the centrifuged product is washed with a solvent, centrifuged and washed again, and repeated 3-5 times; the final centrifuged product is placed in a vacuum oven and dried at 60°C until it reaches a constant weight.
其中,所述反应性单体包含:亚甲基丁二酸酐、N-乙烯基吡咯烷酮、交联剂。优选地,所述反应性单体由亚甲基丁二酸酐、N-乙烯基吡咯烷酮和交联剂组成。Wherein, the reactive monomer includes: methylene succinic anhydride, N-vinylpyrrolidone, and a crosslinking agent. Preferably, the reactive monomer consists of methylene succinic anhydride, N-vinylpyrrolidone and a crosslinking agent.
其中,亚甲基丁二酸酐、N-乙烯基吡咯烷酮、交联剂三者之间的用量比范围为:(2~4)∶(1~2)∶(1~2)。优选地,亚甲基丁二酸酐、N-乙烯基吡咯烷酮、交联剂三者之间的用量比范围为:(2~3)∶(1~1.5)∶(1~1.5)。本申请的发明人预料不到地发现,三者的比例在前述范围内能够得到微纳米聚合物凝胶粒子,且所述粒子的球形性好、粒度均匀。Wherein, the range of the usage ratio among methylene succinic anhydride, N-vinylpyrrolidone and crosslinking agent is: (2-4): (1-2): (1-2). Preferably, the range of the amount ratio among methylene succinic anhydride, N-vinylpyrrolidone and crosslinking agent is: (2-3):(1-1.5):(1-1.5). The inventors of the present application unexpectedly found that micro-nano polymer gel particles can be obtained when the ratio of the three is within the aforementioned range, and the particles have good sphericity and uniform particle size.
其中,所述交联剂为具有两个以上可聚合结构的分子,这类分子包括但不限于:二乙烯基苯、二甲基丙烯酸乙二醇酯、N,N′-亚甲基双丙烯酰胺、聚乙二醇双丙烯酸酯。Wherein, the crosslinking agent is a molecule having more than two polymerizable structures, such molecules include but not limited to: divinylbenzene, ethylene glycol dimethacrylate, N,N'-methylenebispropylene Amide, polyethylene glycol diacrylate.
所述单体含量占溶液总量的1%-50%,优选5%-20%;其中,交联剂含量占其他单体总量的0.1%-15%,优选1%-10%。The content of the monomer accounts for 1%-50% of the total solution, preferably 5%-20%; wherein, the content of the crosslinking agent accounts for 0.1%-15% of the total amount of other monomers, preferably 1%-10%.
其中,所述聚合引发剂选自本领域专业技术人员所公知的热聚合引发剂,这类引发剂包括但不限于:异丙苯过氧化氢、叔丁基过氧化氢、过氧化二异丙苯、过氧化二特丁基、过氧化十二酰、过氧化二苯甲酰、过氧化苯甲酸特丁酯、过氧化二碳酸二异丙基酯、过氧化二碳酸二环己酯、偶氮二异丁腈、偶氮二异庚腈中的至少一种。Wherein, the polymerization initiator is selected from thermal polymerization initiators known to those skilled in the art, such initiators include but not limited to: cumene hydroperoxide, tert-butyl hydroperoxide, diisopropyl peroxide Benzene, di-tert-butyl peroxide, lauryl peroxide, dibenzoyl peroxide, tert-butyl peroxybenzoate, diisopropyl peroxydicarbonate, dicyclohexyl peroxydicarbonate, At least one of azobisisobutyronitrile and azobisisoheptanonitrile.
所述聚合引发剂含量占溶液总量的0.01%-0.5%,优选0.01%-0.1%。The content of the polymerization initiator accounts for 0.01%-0.5% of the total solution, preferably 0.01%-0.1%.
其中,所述溶剂对于实现本发明中的亚甲基丁二酸酐、N-乙烯基吡咯烷酮、交联剂的聚合反应从而得到微纳米聚合物凝胶粒子非常关键。所述溶剂必须对于亚甲基丁二酸酐、N-乙烯基吡咯烷酮、交联剂和引发剂都有良好的溶解作用,以保证反应前为均相体系;而且,所述溶剂必须对于所生成的共聚物大分子链不能溶解,当大分子链达到一定的临界长度后便从介质中沉析出来,形成微纳米聚合物凝胶粒子分散于反应溶剂当中。Wherein, the solvent is very critical for realizing the polymerization reaction of methylene succinic anhydride, N-vinylpyrrolidone and crosslinking agent in the present invention to obtain micronano polymer gel particles. Described solvent must all have good dissolving effect for methylene succinic anhydride, N-vinylpyrrolidone, linking agent and initiator, to guarantee that it is homogeneous system before reaction; And, described solvent must be for generated The macromolecular chain of the copolymer cannot be dissolved, and when the macromolecular chain reaches a certain critical length, it will precipitate out of the medium to form micro-nano polymer gel particles dispersed in the reaction solvent.
所述溶剂选自以下三类:(a)有机酸烷基酯:甲酸酯、乙酸乙酯、乙酸丁酯、乙酸异丁酯、乙酸仲丁酯、乙酸戊酯、乙酸异戊酯、乙酸苄酯、丙酸甲酯、丙酸乙酯、丙酸丁酯、丁酸甲酯、丁酸乙酯、丁酸丁酯、丁酸异戊酯、苯甲酸甲酯、苯甲酸乙酯、苯甲酸丙酯、苯甲酸丁酯、苯甲酸异戊酯、苯乙酸甲酯、苯乙酸乙酯;(b)酮类:丙酮、甲乙酮、戊酮、环己酮;(c)烷烃类:正己烷、环己烷、正庚烷。优选地,所述溶剂由有机酸烷基酯、酮类、烷烃类组合而成。Described solvent is selected from following three classes: (a) organic acid alkyl ester: formate, ethyl acetate, butyl acetate, isobutyl acetate, sec-butyl acetate, pentyl acetate, isopentyl acetate, acetic acid Benzyl ester, Methyl propionate, Ethyl propionate, Butyl propionate, Methyl butyrate, Ethyl butyrate, Butyl butyrate, Isoamyl butyrate, Methyl benzoate, Ethyl benzoate, Benzene Propyl formate, butyl benzoate, isoamyl benzoate, methyl phenylacetate, ethyl phenylacetate; (b) ketones: acetone, methyl ethyl ketone, pentanone, cyclohexanone; (c) alkanes: n-hexane , cyclohexane, n-heptane. Preferably, the solvent is composed of organic acid alkyl esters, ketones, and alkanes.
优选地,有机酸烷基酯、酮类、烷烃类三者之间的用量比范围为:(5~8)∶(1~3)∶(1~2)。优选地,有机酸烷基酯、酮类、烷烃类三者之间的用量比范围为:(6~7)∶(1~2)∶(1~1.5)。更优选地,所述溶剂由乙酸丁酯、环己酮和环己烷组成。Preferably, the range of the usage ratio among organic acid alkyl esters, ketones and alkanes is: (5-8):(1-3):(1-2). Preferably, the range of the usage ratio among organic acid alkyl esters, ketones and alkanes is: (6-7):(1-2):(1-1.5). More preferably, the solvent consists of butyl acetate, cyclohexanone and cyclohexane.
需要特别说明的是,本聚合反应体系在无分散剂添加的情况下亦可正常反应并得到微纳米聚合物凝胶粒子,这是本发明制备方法与一般聚合物凝胶粒子制备方法的不同。It should be noted that this polymerization reaction system can also react normally and obtain micro-nano polymer gel particles without adding a dispersant, which is the difference between the preparation method of the present invention and the general polymer gel particle preparation method.
其中,所述搅拌速率为0-450rpm,即在搅拌速率为0的情况下,亦可正常反应并制备聚合物乳胶粒子,与搅拌条件下的反应相比,粒子的形态和大小会有所不同。这是本发明制备聚合物乳胶粒子工艺方法的又一特色。Wherein, the stirring rate is 0-450rpm, that is, when the stirring rate is 0, the polymer latex particles can also be reacted normally and prepared. Compared with the reaction under stirring conditions, the shape and size of the particles will be different . This is another feature of the process for preparing polymer latex particles of the present invention.
用HITACHIH-800透射电子显微镜观察不同制备条件下得到的微纳米聚合物凝胶粒子。将离心洗涤后的产物用溶剂分散、稀释,超声震荡15分钟,然后用滴管吸取少量样品滴于电镜铜网上,自然晾干。铜网上面已覆盖聚乙烯醇缩丁醛支撑膜,并进行了表面喷碳处理。The micro-nano polymer gel particles obtained under different preparation conditions were observed with HITACHIH-800 transmission electron microscope. Disperse and dilute the product after centrifugation and washing with a solvent, vibrate ultrasonically for 15 minutes, then use a dropper to draw a small amount of sample and drop it on the copper grid of the electron microscope, and let it dry naturally. The copper mesh has been covered with polyvinyl butyral support film, and the surface has been sprayed with carbon.
用MalvemMastersize2000激光粒度分析仪测定聚合物凝胶粒子的粒径和粒径分布。将离心洗涤后的产物用溶剂分散、稀释(稀释度1000倍以上),在超声波发生器中充分震荡,使粒子散开,然后进行仪器分析。数据统计分析方法如下:The particle size and particle size distribution of the polymer gel particles were measured with a MalvemMastersize2000 laser particle size analyzer. Disperse and dilute the product after centrifugation and washing with a solvent (the dilution rate is more than 1000 times), fully vibrate in an ultrasonic generator to disperse the particles, and then carry out instrumental analysis. The data statistical analysis method is as follows:
PDI=dw/dn PDI= dw / dn
式中di-单个微球粒径;dn-微球数均粒径;dw-微球重均粒径;n-样本容量;PDI-粒径分布指数。In the formula, d i - single microsphere particle size; d n - microsphere number average particle size; d w - microsphere weight average particle size; n - sample volume; PDI - particle size distribution index.
用ThermoNicoletNexus670傅立叶变换红外光谱仪测定微纳米聚合物凝胶粒子的化学结构。The chemical structure of micro-nano polymer gel particles was determined by ThermoNicolet Nexus670 Fourier transform infrared spectrometer.
实施例1Example 1
亚甲基丁二酸酐0.65g,N-乙烯基吡咯烷酮0.25g,二乙烯基苯0.3g,过氧化二苯甲酰0.01g,乙酸丁酯72mL,环己酮12mL,正己烷15mL,加入到250mL三口烧瓶中充分溶解;通氮排氧20min;将溶液体系置于恒温水浴中加热引发聚合反应,温度保持在85℃,反应8h结束。产物用离心机于5000rpm分离,用乙酸丁酯进行洗涤,再次离心分离、洗涤,重复3次;将最终的离心产物放入真空烘箱,于60℃温度下烘干至恒重。Methylene succinic anhydride 0.65g, N-vinylpyrrolidone 0.25g, divinylbenzene 0.3g, dibenzoyl peroxide 0.01g, butyl acetate 72mL, cyclohexanone 12mL, n-hexane 15mL, add to 250mL Fully dissolve in a three-necked flask; pass nitrogen and oxygen for 20 minutes; heat the solution system in a constant temperature water bath to initiate polymerization reaction, keep the temperature at 85°C, and complete the reaction for 8 hours. The product was separated with a centrifuge at 5000 rpm, washed with butyl acetate, centrifuged again and washed three times; the final centrifuged product was placed in a vacuum oven and dried at 60°C until it reached a constant weight.
所得微纳米聚合物凝胶粒子的透射电子显微镜照片见图1。粒子的平均粒径为76nm,粒径分布指数为1.05,接近单分散性。The transmission electron micrograph of the obtained micro-nano polymer gel particles is shown in FIG. 1 . The average particle diameter of the particles is 76nm, and the particle size distribution index is 1.05, which is close to monodispersity.
实施例2Example 2
其他条件与实施例1相同,不同之处仅在于亚甲基丁二酸酐、N-乙烯基吡咯烷酮、二乙烯基苯三者的用量分别为1.5g、0.8g、1.2g。Other conditions were the same as in Example 1, except that the amounts of methylene succinic anhydride, N-vinylpyrrolidone, and divinylbenzene were 1.5 g, 0.8 g, and 1.2 g, respectively.
所得微纳米聚合物凝胶粒子的透射电子显微镜照片见图2。粒子的平均粒径为115nm,粒径分布指数为1.03,接近单分散性,表明随着单体浓度的增加,聚合物凝胶粒子的粒径增大。The transmission electron micrograph of the obtained micro-nano polymer gel particles is shown in FIG. 2 . The average particle size of the particles is 115nm, and the particle size distribution index is 1.03, which is close to monodispersity, indicating that the particle size of the polymer gel particles increases with the increase of the monomer concentration.
实施例3Example 3
其他条件与实施例1相同,不同之处仅在于所用单体为:亚甲基丁二酸酐、N-乙烯基吡咯烷酮、聚乙二醇双丙烯酸酯,三种单体的用量分别为2.6g、1.25g、1.5g。Other conditions are the same as in Example 1, except that the monomers used are: methylene succinic anhydride, N-vinylpyrrolidone, polyethylene glycol diacrylate, and the consumption of the three monomers is respectively 2.6g, 1.25g, 1.5g.
所得微纳米聚合物凝胶粒子的透射电子显微镜照片见图3。粒子的平均粒径为212nm,粒径分布指数为1.06,接近单分散性,表明改变交联剂的种类仍可以得到聚合物凝胶粒子,而且随着单体浓度的增加,聚合物凝胶粒子的粒径增大。The transmission electron micrograph of the obtained micro-nano polymer gel particles is shown in FIG. 3 . The average particle size of the particles is 212nm, and the particle size distribution index is 1.06, which is close to monodispersity, indicating that polymer gel particles can still be obtained by changing the type of crosslinking agent, and as the monomer concentration increases, the polymer gel particles particle size increases.
实施例4Example 4
所用单体种类和用量与实施例3相同,不同之处仅在于所用混合溶剂的组成为:乙酸丁酯70mL,环己酮12mL,正己烷10mL。The type and amount of the monomers used are the same as in Example 3, except that the mixed solvent used consists of: 70 mL of butyl acetate, 12 mL of cyclohexanone, and 10 mL of n-hexane.
所得微纳米聚合物凝胶粒子的透射电子显微镜照片见图4。粒子的平均粒径为370nm,粒径分布指数为1.05,接近单分散性,表明在单体种类和用量保持不变的情况下,通过改变反应溶剂的种类和配比,可以调控聚合物凝胶粒子的粒径。The transmission electron micrograph of the obtained micro-nano polymer gel particles is shown in FIG. 4 . The average particle size of the particles is 370nm, and the particle size distribution index is 1.05, which is close to monodispersity, indicating that the polymer gel can be adjusted by changing the type and proportion of the reaction solvent while the type and amount of the monomer remain unchanged. particle size.
实施例5Example 5
所用单体种类和用量与实施例3相同,不同之处仅在于所用混合溶剂的组成为:乙酸丁酯65mL,环己酮20mL,正己烷10mL。The type and amount of the monomers used are the same as in Example 3, except that the mixed solvent used consists of 65 mL of butyl acetate, 20 mL of cyclohexanone, and 10 mL of n-hexane.
所得微纳米聚合物凝胶粒子的透射电子显微镜照片见图5。粒子的平均粒径为565nm,粒径分布指数为1.13,表明随着酮类溶剂的用量增加,粒子的球形性变差,粒子之间有粘连。The transmission electron micrograph of the obtained micro-nano polymer gel particles is shown in FIG. 5 . The average particle size of the particles is 565nm, and the particle size distribution index is 1.13, indicating that with the increase of the amount of ketone solvent, the sphericity of the particles becomes worse, and there is adhesion between the particles.
实施例6Example 6
所用单体种类和用量与实施例3相同,不同之处仅在于所用混合溶剂的组成为:乙酸丁酯65mL,环己酮12mL,正己烷20mL。The type and amount of the monomers used are the same as in Example 3, except that the mixed solvent used consists of 65 mL of butyl acetate, 12 mL of cyclohexanone, and 20 mL of n-hexane.
所得微纳米聚合物凝胶粒子的透射电子显微镜照片见图6。粒子的平均粒径为768nm,粒径分布指数为1.24,表明随着烷烃类溶剂的用量增加,粒子的球形性变差,粒子之间有粘连。The transmission electron micrograph of the obtained micro-nano polymer gel particles is shown in FIG. 6 . The average particle size of the particles is 768nm, and the particle size distribution index is 1.24, indicating that with the increase of the amount of alkane solvent, the sphericity of the particles becomes worse, and there is adhesion between the particles.
对比例1Comparative example 1
其他条件与实施例1相同,不同之处仅在于单体中不含交联剂二乙烯基苯。结果显示:所得反应产物为聚合物胶状物质,不能得到聚合物凝胶粒子,表明交联剂对形成聚合物凝胶粒子非常重要。Other conditions are the same as in Example 1, except that the monomer does not contain the crosslinking agent divinylbenzene. The results showed that the obtained reaction product was a polymer colloidal substance, and the polymer gel particles could not be obtained, which indicated that the crosslinking agent was very important for the formation of the polymer gel particles.
对比例2Comparative example 2
其他条件与实施例1相同,不同之处仅在于亚甲基丁二酸酐、N-乙烯基吡咯烷酮、二乙烯基苯三者的用量分别为2.6g、1.25g、0.2g。结果显示:所得反应产物中含有聚合物胶状物质,有少量聚合物凝胶粒子但互相粘连,表明交联剂用量对形成完整的聚合物凝胶粒子非常重要。Other conditions were the same as in Example 1, except that the amounts of methylene succinic anhydride, N-vinylpyrrolidone, and divinylbenzene were 2.6 g, 1.25 g, and 0.2 g, respectively. The results showed that: the obtained reaction product contained polymer colloidal substances, and there were a small amount of polymer gel particles but adhered to each other, indicating that the amount of cross-linking agent was very important for the formation of complete polymer gel particles.
对比例3Comparative example 3
其他条件与实施例1相同,不同之处仅在于所用混合溶剂的组成为:环己酮80mL,正己烷15mL,不含乙酸丁酯。结果显示:所得反应产物为聚合物胶状物质,不能得到聚合物凝胶粒子。表明溶剂种类和配比对聚合物凝胶粒子的形成非常重要。Other conditions were the same as in Example 1, except that the mixed solvent used consisted of: 80 mL of cyclohexanone, 15 mL of n-hexane, and no butyl acetate. The results showed that the obtained reaction product was a polymer colloidal substance, and polymer gel particles could not be obtained. It shows that the solvent type and ratio are very important to the formation of polymer gel particles.
对比例4Comparative example 4
其他条件与实施例1相同,不同之处仅在于所用混合溶剂的组成为:乙酸丁酯65mL,环己酮30mL,不含正己烷。结果显示:所得反应产物中含有聚合物胶状物质,有少量聚合物凝胶粒子但互相粘连,表明溶剂种类和配比对完整聚合物凝胶粒子的形成非常重要。Other conditions were the same as in Example 1, except that the mixed solvent used consisted of: 65 mL of butyl acetate, 30 mL of cyclohexanone, and no n-hexane. The results show that the obtained reaction product contains polymer colloidal substances, and there are a small amount of polymer gel particles but adhere to each other, indicating that the solvent type and ratio are very important for the formation of complete polymer gel particles.
对比例5Comparative example 5
其他条件与实施例1相同,不同之处仅在于所用混合溶剂的组成为:乙酸丁酯65mL,正己烷30mL,不含环己酮。结果显示:所得反应产物中含有聚合物胶状物质,有少量聚合物凝胶粒子但球形性不好,而且粒径不均匀,表明溶剂种类和配比对完整聚合物凝胶粒子的形成非常重要。Other conditions were the same as in Example 1, except that the mixed solvent used consisted of: 65 mL of butyl acetate, 30 mL of n-hexane, and no cyclohexanone. The results show that the obtained reaction product contains polymer colloidal substances, and there are a small amount of polymer gel particles, but the sphericity is not good, and the particle size is uneven, indicating that the solvent type and ratio are very important for the formation of complete polymer gel particles .
应当指出,以上所述具体实施方式可以使本领域的技术人员更全面地理解本创新发明,但不以任何方式限制本创新发明。因此,尽管本说明书通过实施例对本创新发明已进行了详细的说明,但是,本领域技术人员应当理解,一切不脱离本创新发明的精神实质和范围的技术方案及其改进,其均应涵盖在本创新发明专利的保护范围当中。It should be pointed out that the specific embodiments described above can enable those skilled in the art to understand the innovative invention more comprehensively, but it does not limit the innovative invention in any way. Therefore, although this specification has described the innovative invention in detail through the embodiments, those skilled in the art should understand that all technical solutions and improvements thereof that do not depart from the spirit and scope of the innovative invention should be included in the Among the protection scope of this innovative invention patent.
Claims (5)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410290931.XA CN104119475B (en) | 2014-06-26 | 2014-06-26 | A kind of surface-functionalized micro-nano polymer gel particle and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410290931.XA CN104119475B (en) | 2014-06-26 | 2014-06-26 | A kind of surface-functionalized micro-nano polymer gel particle and preparation method thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104119475A CN104119475A (en) | 2014-10-29 |
CN104119475B true CN104119475B (en) | 2016-06-15 |
Family
ID=51765131
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410290931.XA Expired - Fee Related CN104119475B (en) | 2014-06-26 | 2014-06-26 | A kind of surface-functionalized micro-nano polymer gel particle and preparation method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104119475B (en) |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NZ569372A (en) * | 2005-12-28 | 2011-10-28 | Fresenius Kabi Oncology Ltd | A biocompatible, non-biodegradable, non-toxic polymer useful for nanoparticle pharmaceutical compositions |
CN101597352B (en) * | 2009-06-26 | 2011-05-18 | 北京化工大学 | Crosslinking sodium p-styrenesulfonate-maleic anhydride high polymer and photopolymerization preparation method thereof |
-
2014
- 2014-06-26 CN CN201410290931.XA patent/CN104119475B/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CN104119475A (en) | 2014-10-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN107550921B (en) | A nanoparticle-polymer injectable composite hydrogel dual drug-loading system and preparation method thereof | |
CN105250214B (en) | A kind of preparation method of the polymer nano hydrogel pharmaceutical carrier of amino acid modification | |
CN101113183A (en) | Monodisperse nano/micro polymer hollow microsphere resin and synthesis method thereof | |
CN103833915A (en) | Molecular imprinting polymer nanoparticles for pure biological sample, and preparation method thereof | |
CN109453378A (en) | A kind of laser nano-control particle assembly body and the preparation method and application thereof | |
CN104725581B (en) | The preparation of light/temperature responsive type Amphipathilic block polymer micelle and application process | |
CN113457587A (en) | Multiple-response core-shell structure nanogel and preparation method and application thereof | |
CN105646800A (en) | Method for preparing rosin-based hydroxylation polymer micro-spheres | |
CN107082840A (en) | Acrylamide phenyl boric acid polymer and preparation and application thereof | |
CN107522824A (en) | A kind of preparation method of protein/macromolecule composite aquogel microballoon | |
CN104151563A (en) | Gold nano particles coated with amphiphilic polymer self-assembly micelle with photoresponse | |
Wang et al. | One-pot synthesis of mushroom-shaped polymeric Janus particles by soap-free emulsion copolymerization | |
Ma et al. | Yeast cells encapsulating polymer nanoparticles as Trojan particles via in situ polymerization inside cells | |
Calandrelli et al. | Novel graft PLLA‐based copolymers: Potential of their application to particle technology | |
CN106565908B (en) | A kind of preparation method of monodispersed large grain-size polymer microballoon | |
Gao et al. | Polyethyleneimine functionalized polymer microsphere: a novel delivery vector for cells | |
CN103240120B (en) | Temperature switch type catalyst based on magnetic artificial cells | |
CN104119475B (en) | A kind of surface-functionalized micro-nano polymer gel particle and preparation method thereof | |
CN101766981A (en) | Method for preparing polymer microsphere by utilizing rosin and crylic acid hydroxy ester | |
CN102659980A (en) | Method for preparing double hydrophilic thermo-sensitive polymer nano micelles | |
CN101955571A (en) | Method for preparing rosin-based polymer microspheres | |
Wei et al. | Facile fabrication of thermosensitive hydrogel microspheres based on a combination of metal-free click chemistry and spray drying | |
CN103214609A (en) | Preparation method of monodisperse rosinyl polymer microsphere | |
CN105078924B (en) | A kind of sodium alginate base pH response type drug microcapsules and preparation method thereof | |
CN109402177A (en) | A kind of nano carrier material and preparation method thereof suitable for foreign gene transfection |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20160615 Termination date: 20190626 |